11C-MePPEP

N/A

Report date: 2025/12/02 11:25:37
NME

Base Information

Drug Name11C-MePPEP
Drug Alias Name11C-MePPEP
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5
Mechanisms of ActionCannabinoid CB1 receptor modulators
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsSubstance-Related DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Active IndicationsSubstance-Related DisordersObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A